Tiziana Life Sciences (TLSA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tiziana Life Sciences Ltd. has announced the voluntary resignation of its Chief Operating Officer and Chief Medical Officer, Matthew W Davis, MD, RPh, effective from August 2, 2024. The departure is due to personal reasons, with no reported disputes concerning company operations, policies, or practices. A search for Dr. Davis’ successor is underway, with further updates to come once a replacement is appointed.
For further insights into TLSA stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- ‘Time to Get Off This Train,’ Says Top Analyst About Rigetti Computing Stock Ahead of Earnings
- AMD Stock Heads Into Tuesday’s Earnings With Momentum — Here’s What This Top Investor Expects
- ‘The Big Vote Coming’: Daniel Ives Weighs In on Tesla Stock as Shareholders Decide Musk’s $1 Trillion Pay Package